Evidence map›Paper›PMID 27138383›Full record

ArticleAnnals of surgical oncology2016

Antiplatelet and Anticoagulant Medications Significantly Increase the Risk of Postoperative Hematoma: Review of over 4500 Thyroid and Parathyroid Procedures.

Sarah C Oltmann, Amal Y Alhefdhi, Mohammad H Rajaei, David F Schneider, Rebecca S Sippel, Herbert Chen

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Annals of surgical oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04852406 (Effect of Protocol-based Management on Perioperative Outcomes in Patients With Chronic Antithrombotic Therapy), which is not on this map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04852406 narecruitingnot on this mapstarted 2021, after this paper: background citation

Effect of Protocol-based Management on Perioperative Outcomes in Patients With Chronic Antithrombotic Therapy: a Pragmatic Interventional Study

TypeinterventionalSponsorPeking University First HospitalRan2021 to 2026Enrolled526ConditionsAntithrombotic Therapy, Perioperative Care, Perioperative OutcomesArmsProtocol-based management of perioperative antithrombotic therapy, Routine management of perioperative antithrombotic therapy
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Sarah C OltmannDepartment of Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA. sarah.oltmann@utsouthwestern.edu.
Amal Y AlhefdhiDepartment of Surgery, The King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Mohammad H RajaeiDepartment of Surgery, University of Wisconsin, Madison, WI, USA.
David F SchneiderDepartment of Surgery, University of Wisconsin, Madison, WI, USA.
Rebecca S SippelDepartment of Surgery, University of Wisconsin, Madison, WI, USA.
Herbert ChenDepartment of Surgery, University of Alabama at Birmingham, Birmingham, AL, USA.
University of Wisconsin–Madison · USKing Faisal Specialist Hospital & Research Centre · SAThe University of Texas Southwestern Medical Center · USUniversity of Alabama at Birmingham · US

Funding

Central Neck Dissection in Patients with Clinical Node Negative Thyroid CancerR01CA176911 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI CONNOR, NADINE P, SIPPEL, REBECCA S · 2014 to 2019
$1.8M
NCI NIH HHS R01 CA176911
6 · The paper itself

Abstract

purposeAntiplatelet and/or anticoagulant medication use is common. Abstinence a week before surgery may still result in altered hemostasis. The study aim was to report on perioperative antiplatelet and anticoagulant use in thyroidectomy and parathyroidectomy patients, and to determine the association with postoperative hematoma (POH) rates.

methodsRetrospective review of a prospective endocrine surgery database was performed. Procedure extent was defined as unilateral, bilateral, or extensive. Antiplatelets were categorized as none, 325 mg aspirin (ASA), <325 mg ASA, clopidogrel, or other. Anticoagulants were categorized as none, oral, or injectable.

resultsA total of 4514 patients were identified. POH developed in 22 patients (0.5 %). Rates were similar between age, gender, and reoperative status. POH were seven times more common after thyroidectomy (0.8 vs. 0.1 %, p < 0.01). Unilateral procedures had lower POH rates than bilateral or extensive (0.1 vs. 0.9 vs. 0.8 %, p < 0.01). POH rates in patients receiving 325 mg ASA (0.8 %) or clopidogrel (2.2 %) were much higher than patients not receiving antiplatelets (0.5 %) or receiving <325 mg ASA (0.1 %, p = 0.04). Oral anticoagulants (2.2 %) and injectable anticoagulants (10.7 %) had much higher POH rates than patients not receiving anticoagulants (0.4 %, p < 0.01). Target organ, patient gender, procedure extent, antiplatelet use, and anticoagulant use were included on logistic regression to determine association with POH. Bilateral procedures, thyroidectomy, clopidogrel, oral, and injectable anticoagulants were all independently associated with POH.

conclusionsPOH occur more frequently after thyroidectomy and during bilateral procedures. Patients requiring clopidogrel or any anticoagulant coverage are at much higher risk for POH. These higher-risk patients should be considered for observation to ensure prompt POH recognition and intervention.

Indexed as

AnticoagulantsAspirinClopidogrelFemaleHematomaHumansMaleMiddle AgedParathyroidectomyPlatelet Aggregation InhibitorsPostoperative ComplicationsRetrospective StudiesRisk FactorsThyroidectomyTiclopidineAnticoagulantsAspirinClopidogrelPlatelet Aggregation InhibitorsTiclopidine

Identifiers

PMID27138383
PMCPMC5120859
OpenAlexW2345554485

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.